Skip to content

Comparison of the Effectiveness of 16 days Medicated Enema from Kshara Basti and Navak Guggul Versus Ayurvedic 16 days Medicated Enema from Lekhana Basti and Navak Guggul In The Management Of Obesity A Randomized Controlled Trial

Evaluation of Comparative Efficacy of Kshara Basti in Kaal Basti Kram and Navak Guggul Versus Lekhana Basti in Kaal Basti Kram and Navak Guggul in the Management of Sthoulya - A Randomized Controlled Trial - Nil

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/114071
Enrollment
200
Registered
2026-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing for Informed Consent. 2. Subjects between the age group of 25 and 55 years and irrespective of Age/Sex. 3. Subjects with Pratyatma Lakshanas of Sthoulya and clinical features of Obesity 4. B.M.I in between 26- 35 5. Subjects fulfilling the eligibility criteria of Basti.

Exclusion criteria

Exclusion criteria: 1. The patient having B.M.I. greater than 35 will also be excluded 2. Patients with Endocrinal disorder & other systemic diseases i.e Hypothyroidism TSH level More than 10. 3. Patients with long term Steroid treatment. 4. Patients suffering from NAFLD Non Alcoholic Fatty Liver Disease 5. Patient having Eczema, Psoriasis, Cuts, Burns, wounds. 6. Pregnant & lactating mother and women in the menstruation cycle.

Design outcomes

Primary

MeasureTime frame
Use of Kshar Basti in Kaal Basti Kram and Navak Guggul and Lekhana Basti in Kaal Basti Kram with Navak Guggul will be effective in the Management of SthoulyaTimepoint: 3 month approx

Secondary

MeasureTime frame
1. This treatment protocol will help in widening therapeutic option for obesity 2.It will help to develop through T3 level evidenceTimepoint: 3 month approx

Countries

India

Contacts

Public ContactDr Rakesh Kumar Mishra

MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTRE SALOD H WARDHA

shweta.parwe@dmiher.edu.in9511659185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026